ASTERDM · Healthcare
The board meets on 6 Nov 2026 to approve the results. This page fills in when the numbers are filed.
| Q2 FY24 | Q3 FY24 | Q4 FY24 | Q1 FY25 | Q2 FY25 | Q3 FY25 | Q4 FY25 | Q1 FY26 | Q2 FY26 | Q3 FY26 | Q4 FY26 | Q1 FY27 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | ₹929 cr | ₹955 cr | ₹974 cr | ₹1,002 cr | ₹1,086 cr | ₹1,050 cr | ₹1,000 cr | ₹1,078 cr | ₹1,197 cr | ₹1,186 cr | ₹1,182 cr | ₹1,311 cr |
| YoY | — | — | — | +19% | +17% | +10% | +3% | +8% | +10% | +13% | +18% | +22% |
| EBITDA margin | 15.3% | 15.6% | 16.0% | 16.1% | 20.0% | 17.7% | 18.2% | 18.7% | 19.7% | 17.0% | 19.0% | 19.5% |
| Other income, % of PBT | — | 70% | −143% | 99% | 22% | 9% | 5% | 21% | 17% | 0% | 23% | −99% |
| Exceptional items | — | — | — | — | — | — | — | — | — | — | — | — |
| Tax rate | — | 5% | — | 1% | 33% | 37% | 6% | 31% | 27% | 43% | 6% | 62% |
| Net profit | −₹15.0 cr | ₹209 cr | −₹2.0 cr | ₹5,152 cr | ₹106 cr | ₹64.0 cr | ₹86.0 cr | ₹94.0 cr | ₹121 cr | ₹59.0 cr | ₹154 cr | ₹29.0 cr |
| YoY | — | — | — | +25,660% | — | −69% | — | −98% | +14% | −8% | +79% | −69% |
| Core profit YoY | — | — | — | +65% | +118% | +39% | +26% | +51% | +12% | +11% | +47% | +45% |
| EPS | −₹0.62 | ₹3.59 | −₹0.48 | ₹103.00 | ₹1.94 | ₹1.14 | ₹1.58 | ₹1.65 | ₹2.12 | ₹1.01 | ₹2.71 | ₹0.31 |
| Flags | · | 1 | · | 3 | ✓ | ✓ | 1 | ✓ | ✓ | ✓ | 2 | ✓ |
Each quarter is read with the same rules. Balance-sheet and cash checks run on half-year and annual quarters; filing-read checks run where a read exists.
Numbers as filed with the exchanges, read by rules. Every flag is a question with its source, not an accusation. FinMinutes is a financial data and analytics platform; nothing here is a recommendation to buy, sell or hold any security. How each check works.